Helsinn Therapeutics Inc. to obtain all rights to promote and distribute AKYNZEO® (netupitant/palonosetron)
Eisai and Helsinn to continue to co-promote and distribute ALOXI® (palonosetron HCl) injection
Helsinn and Eisai Announce Revised U.S. Collaboration for CINV Franchise
![Helsinn Healthcare SA](http://www.farmaindustriaticino.ch/files/2015/05/logo_helsinn.png)
Linkedin